# Enliven Therapeutics (ELVN) - Q2 2026 earnings

Reported August 5, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | Not available |
| EPS | $-0.49 | $-0.39 |

Earnings filing reader: [8-K 0001193125-26-335101](https://www.opencapital.sh/filings/0001193125-26-335101)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-335101.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1672619/000119312526335101/0001193125-26-335101-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1672619/000119312526335155/0001193125-26-335155-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/elvn/earnings/q2-2026